Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
Publication
, Journal Article
Antoszyk, AN; Tarnowski, KW; Basu, K; Ehrlich, JS; Haskova, Z
Published in: Ophthalmol Retina
October 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ophthalmol Retina
DOI
EISSN
2468-6530
Publication Date
October 2020
Volume
4
Issue
10
Start / End Page
1034 / 1036
Location
United States
Related Subject Headings
- Visual Acuity
- Vascular Endothelial Growth Factor A
- Tomography, Optical Coherence
- Ranibizumab
- Macular Edema
- Intravitreal Injections
- Humans
- Diabetic Retinopathy
- Angiogenesis Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Antoszyk, A. N., Tarnowski, K. W., Basu, K., Ehrlich, J. S., & Haskova, Z. (2020). Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema. Ophthalmol Retina, 4(10), 1034–1036. https://doi.org/10.1016/j.oret.2020.05.020
Antoszyk, Andrew N., Kathleen Wade Tarnowski, Karen Basu, Jason S. Ehrlich, and Zdenka Haskova. “Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.” Ophthalmol Retina 4, no. 10 (October 2020): 1034–36. https://doi.org/10.1016/j.oret.2020.05.020.
Antoszyk AN, Tarnowski KW, Basu K, Ehrlich JS, Haskova Z. Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema. Ophthalmol Retina. 2020 Oct;4(10):1034–6.
Antoszyk, Andrew N., et al. “Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.” Ophthalmol Retina, vol. 4, no. 10, Oct. 2020, pp. 1034–36. Pubmed, doi:10.1016/j.oret.2020.05.020.
Antoszyk AN, Tarnowski KW, Basu K, Ehrlich JS, Haskova Z. Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema. Ophthalmol Retina. 2020 Oct;4(10):1034–1036.
Published In
Ophthalmol Retina
DOI
EISSN
2468-6530
Publication Date
October 2020
Volume
4
Issue
10
Start / End Page
1034 / 1036
Location
United States
Related Subject Headings
- Visual Acuity
- Vascular Endothelial Growth Factor A
- Tomography, Optical Coherence
- Ranibizumab
- Macular Edema
- Intravitreal Injections
- Humans
- Diabetic Retinopathy
- Angiogenesis Inhibitors